Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (16)

2024

  1. Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection

    Cancer Treatment Reviews, Vol. 125

  2. Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group

    Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 171-177

2023

  1. Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers

    Frontiers in Immunology, Vol. 14

2022

  1. A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy

    Scientific Reports, Vol. 12, Núm. 1

  3. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

    Clinical Epigenetics, Vol. 14, Núm. 1

  4. Venous Thromboembolism In Cancer Patients: “From Evidence to Care”

    Clinical and Applied Thrombosis/Hemostasis, Vol. 28

2021

  1. Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence

    Clinical and Translational Oncology, Vol. 23, Núm. 6, pp. 1034-1046

  2. Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method

    Healthcare (Switzerland), Vol. 9, Núm. 6

  3. Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer

    Journal of B.U.ON., Vol. 26, Núm. 5, pp. 2131-2140

  4. Evaluation of a targeted next-generation sequencing panel for the non-invasive detection of variants in circulating dna of colorectal cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  5. Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy

    Cancer Immunology, Immunotherapy, Vol. 70, Núm. 5, pp. 1177-1188

  6. Molecularly targeted therapy in metastatic CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 357-364

2019

  1. Is there any affordable and reliable score in local gastric cancer?

    Annals of Oncology, Vol. 30, pp. iv60

2018

  1. Pleiotropic effects of heparins: does anticoagulant treatment increase survival in cancer patients?

    Clinical and Translational Oncology, Vol. 20, Núm. 9, pp. 1097-1108

2013

  1. Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer

    Oncology Reports, Vol. 29, Núm. 6, pp. 2467-2472